BSI-093 | Interleukin Related interleukin-related.com

Product Name :
BSI-093

Search keywords :
BTN3A1

drugId :
null

Target Vo:
Butyrophilin subfamily 3 member A1

Target Vo Short Name :
CD277

Moa_Name:
Anti-Butyrophilin subfamily 3 member A1

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Biosion Inc

Active Company_Name :
Biosion Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Erk1 (pT202/pY204) + Erk2 (pT185/pY187) Rabbit mAb custom synthesis
SOX1 Rabbit mAb Cancer
RhoA Antibody: RhoA Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to RhoA. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts